AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Salarius Pharmaceuticals, Inc. Director's Dealing 2015

Nov 20, 2015

Director's Dealing

Opens in your device viewer

Issuer: Flex Pharma, Inc. (FLKS)
CIK: 0001615219
Period of Report: 2015-11-11

Reporting Person: PEREZ ROBERT J (Director)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-11-11	Stock Option (right to buy)	$11.05	A	20000	Acquired	2025-11-11	Common Stock (20000.0)	Direct

F1: The stock option will vest in 36 successive equal monthly installments measured from September 2, 2015.